Bing

SEARCH HISTORY

As the stock has dropped by nearly 50% over the past three years, Dr. Shrotriya has earned over $20 million (5% of the market cap) in compensation. On the night that a court ruled against SPPI in a case that opened up its most prominent drug, Fusilev ...
Seeking Alpha · 14 hours ago
Investors in Spectrum Pharmaceuticals Inc (SPPI) saw new options become available this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SPPI options …
The Street · 5/19/2015
Options Trading
Spectrum Pharmaceuticals, Inc. (SPPI) was a big mover last session, as its shares rose over 10% on the day. The upside came on the back of an encouraging announcement by an activist that the company could fetch more than $7.95 a share in a sale.
Yahoo Finance · 5/13/2015
More from Bing News
Over the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move …
ZACKS · 5/13/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks from a “buy” rating to a “hold” rating in a note issued to investors on Friday. Zacks’ analyst wrote, “Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing …
Mideast Times · 5/9/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. Zacks’ analyst wrote, “Spectrum Pharmaceuticals, Inc. is opportunistically ...
Ticker Report · 5/8/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI) posted its quarterly earnings results on Thursday. The company reported ($0.07) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.06) by $0.01, Stock Ratings Network.com reports.
sleekmoney.com · 5/7/2015
The company’s quarterly revenue was down 3.7% on a year-over-year basis. Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) traded down 4.41% on Friday, hitting $5.63. The stock had a trading volume of 883,225 shares. Spectrum Pharmaceuticals …
wkrb13.com · 5/8/2015
Spectrum Pharmaceuticals Inc’s stock traded at artificially inflated prices between August 8, 2012 and March 12, 2013, reaching a high of $13.05 per share on September 18, 2012. Those who purchased shares of Spectrum Pharmaceuticals, Inc.
wallstreetscope.com · 4/29/2015
Rigel Pharma (NASDAQ: RIGL) 42.4% HIGHER; The company and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered into a collaboration agreement for the discovery, development and commercialization of cancer …
StreetInsider · 2/23/2015